Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs
3M geleden•
bullish:
0
bearish:
0
Delen
The once-daily Wegovy pill became the first oral GLP-1 approved for weight loss in the U.S., offering an alternative to injectable treatments that have driven soaring demand.
3M geleden•
bullish:
0
bearish:
0
Delen
Beheer al jouw cryptovaluta, NFT en DeFi vanaf één plekVerbind de portfolio die je gebruikt veilig om te beginnen.